摘要 |
This invention concerns substituted diaza-spiro-[5.5]-undecane derivatives having neurokinin antagonistic activity, in particular NK1 antagonistic activity, a combined NK1/NK2 antagonistic activity, a combined NK1/NK3 antagonistic activity and a combined NK1/NK2/NK3 antagonistic activity, thei r preparation, compositions comprising them and their use as a medicine, in particular for the treatment and/or prophylaxis of schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, pre-eclampsia, nociception, pain, in particular visceral and neuropathic pain, pancreatitis, neurogenic inflammation, asthma, COPD and micturition disorders such as urinary incontinence. The compounds according to the invention can be represented by general Formula (I) (I) and comprises al so the pharmaceutically acceptable acid or base addition salts thereof, the stereochemically isomeric forms thereof, the N-oxide form thereof and prodru gs thereof, wherein all substituents are defined as in Claim 1.
|
申请人 |
JANSSEN PHARMACEUTICA N.V. |
发明人 |
PONCELET, ALAIN PHILIPPE;SIMONNET, YVAN RENE FERDINAND;JANSSENS, FRANS EDUARD;SCHOENTJES, BRUNO;COUPA, SOPHIE |